In agreement with previously published results based on APB detection [9], we confirmed ALT as a prognostic discriminant of increased mortality in liposarcomas and provide the first evidence that sensitivity of the ALT predictive power depends, at least in part, on the marker (APB expression versus TRF length distribution) used. The gene discussed is RNPEP; the disease is liposarcoma.